AstraZeneca’s Digital Solutions Business Could Revolutionize Remote Patient Care

With the introduction of Evinova, a digital health business, AstraZeneca hopes to better accommodate patients, authorisation companies, and medical specialists. 

Benefiting from sustained support from AstraZeneca and forming partnerships with companies such as Parexel and Fortrea, Evinova provides the scientific and healthcare sectors worldwide with automated solutions. 

Evinova aims to decrease the time and expenses associated with progressing new treatments, deliver remote healthcare services to patients, and alleviate the strain on medical systems. 

Evinova has already played a crucial role in the execution of numerous medical studies supported by AstraZeneca, spanning across multiple regions. 

Leading officer of Astrazeneca stated, “We believe Evinova’s combination of scientific expertise and track record in developing AI-enabled digital technologies at scale, provides a real opportunity to fundamentally improve patient care, drive healthcare transformation and reduce carbon emissions.” 

“We are excited to bring the portfolio of globally-scaled digital solutions developed to serve AstraZeneca’s drug development pipeline to the wider life sciences community.” added head of Evinova, Cristina Duran.  

Duran continued by stating, “Coming from within the sector and with proven experience, Evinova will be uniquely placed to deliver science-based, evidence-led and human experience-driven solutions with the aim of improving patient experience and outcomes.” 

© Copyright 2010-2021 Zenopa LTD. All Rights Reserved.